The Department of Chemistry and Applied Biosciences () at ETH Zurich invites applications for the above-mentioned position within the Institute of Pharmaceutical Sciences.
Candidates should have a strong scientific profile related to the discovery and validation of drug targets or identification of novel therapeutic agents.
The fields of research associated with this position should ideally focus on cancer and / or chronic inflammatory diseases.
But other disease areas with the need for improved pharmacotherapies would also be suitable. These disease areas include but are not limited to infectious and haematological diseases, neurological diseases, and metabolic and cardiovascular diseases.
The successful candidate should be involved in translational research activities at least at the preclinical level. A first degree in medicine or pharmacy would be preferable, but non-health professionals with an outstanding research and teaching track record in molecular medicine will be considered as well.
A strong commitment to the teaching activities of the Institute is expected. In general, at ETH Zurich undergraduate level courses are taught in German or English and graduate level courses are taught in English.
Please apply online : www.facultyaffairs.ethz.ch
Applications should include a curriculum vitae, a list of publications, a statement of future research and teaching interests, and a description of the three most important achievements.
The letter of application should be addressed to the President of ETH Zurich, Prof. Dr. Joël Mesot. The closing date for applications is 30 April 2021 .
ETH Zurich is an equal opportunity and family friendly employer, strives to increase the number of women professors, and is responsive to the needs of dual career couples.